Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Traphaco JSCSTC:TRA -2.12%82 5-Year Yield-on-Cost % is 14.71 as of Jul. 19, 2026, which is 30% above its 10-year median of 11.34. GuruFocus rates STC:TRA with a GF Score™ of 82/100 and a GF Value™ of ₫92,491.94 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 513 Drug Manufacturers companies, Traphaco JSC ranks better than 92.98% on this metric.
Traphaco JSC's yield on cost for the quarter that ended in Mar. 2026 was 14.71.
The historical rank and industry rank for Traphaco JSC's 5-Year Yield-on-Cost % or its related term are showing as below:
STC:TRA'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 3.32 Med: 11.34 Max: 23.05
Current: 14.71
During the past 13 years, Traphaco JSC's highest Yield on Cost was 23.05. The lowest was 3.32. And the median was 11.34.
STC:TRA's 5-Year Yield-on-Cost % is ranked better than 92.98% of 513
companies
in the Drug Manufacturers industry
Industry Median: 2.29
vs STC:TRA: 14.71
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Traphaco JSC 5-Year Yield-on-Cost % Related Terms
STC:TRA vs ZTS, UTHR: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Traphaco JSC's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Traphaco JSC 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Traphaco JSC's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Traphaco JSC's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Traphaco JSC is calculated as
Traphaco JSC (STC:TRA) has a 5-Year Yield-on-Cost % of 14.71 as of Jul. 19, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Traphaco JSC and its competitors. This is 30% above median its historical median of 11.34. Over the past decade, Traphaco JSC's 5-Year Yield-on-Cost % has ranged from 3.32 to 23.05. According to the industry distribution chart, Traphaco JSC ranks #36 out of 513 companies in the Drug Manufacturers industry, placing it in the top 7%.
Is Traphaco JSC's 5-Year Yield-on-Cost % too high?
Traphaco JSC's current 5-Year Yield-on-Cost % of 14.71 is 30% above median its 10-year median of 11.34. Over the past 10 years, this metric has ranged from a low of 3.32 to a high of 23.05. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.29. Traphaco JSC's value of 14.71 is 542.4% above this industry median. Based on the distribution chart, Traphaco JSC ranks #36 out of 513 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Traphaco JSC has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Traphaco JSC's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Traphaco JSC ranks #36 out of 513 companies for 5-Year Yield-on-Cost %. This places Traphaco JSC in the top 7% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.29. Traphaco JSC's value of 14.71 is 542.4% above this benchmark. Historically, Traphaco JSC's own 5-Year Yield-on-Cost % has ranged from 3.32 to 23.05 over the past decade. While the company's 10-year median is 11.34 vs. the industry median of 2.29, Traphaco JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.29, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Traphaco JSC's current 5-Year Yield-on-Cost % of 14.71 is 542.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Traphaco JSC and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Traphaco JSC's current 5-Year Yield-on-Cost % is 14.71, which is 30% above median its own 10-year median of 11.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Traphaco JSC stock overvalued right now?
Based on GuruFocus' analysis, Traphaco JSC (STC:TRA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫92,491.94, compared to a current price of ₫78,400.00 — trading 15.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 14.71, which is 30% above median its 10-year median of 11.34 and 542.4% above the Drug Manufacturers industry median of 2.29. Traphaco JSC's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Traphaco JSC (STC:TRA), the current 5-Year Yield-on-Cost % is 14.71 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Traphaco JSC (STC:TRA) Overvalued in 2026?
Based on GuruFocus' analysis, Traphaco JSC stock appears to be undervalued.
The current stock price of ₫78,400.00 is trading 15.2% below its estimated GF Value™ of ₫92,491.94.
GuruFocus considers Traphaco JSC to be Modestly Undervalued.
Key valuation signals for STC:TRA:
5-Year Yield-on-Cost %: 14.71 (30% above median its 10-year median of 11.34)
GF Value™: ₫92,491.94 vs. price of ₫78,400.00 (15.2% below fair value)
Industry Position: 542.4% above the Drug Manufacturers median (#36 of 513)
No single metric tells the full story. See the STC:TRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Traphaco JSC is engaged in the production and trading of pharmaceuticals, chemicals, and medical supplies and equipment. The company's products are used for nourishing the body, the Skeletal system, for hair, for eyes, the Nervous system, the Respiratory system, and Other groups.
82GF Score
Get the complete analysis for STC:TRA
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:TRA has been successfully added to your 
